knowledge -WSS

knowledge

author：fashion 2025-09-28 21:07:17 - browse：8578

Jacob S. Van Naarden (left), Athena Countouriotis( center), and Vlad Coric (right) on stage at the 2023 STAT Summit. — From left, Eli Lilly's Jacob S. Van Naarden, Avenzo's Athena Countouriotis, and Biohaven's Vlad Coric on stage at the 2023 STAT Summit. STAT

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars?

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology, which was acquired by Eli Lilly (where Van Naarden is now executive vice president) for $8 billion in 2019; and Athena Countouriotis, whose company Turning Point Therapeutics was acquired by BMS for $4 billion in 2022.

“Imagine you’re going through your typical day, and you get a message: Albert Bourla, chairman and CEO of Pfizer, wants to talk at six o’clock tonight,” said Coric, whose company had a successful migraine drug on the market and had just completed an IPO at the time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Anthony Fauci pushes back on GOP claims during Covid hearing

entertainment

WSS

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Caregivers of transplant patients call for more support, training

The most pressing bird flu mysteries scientists want answered

The SUPPORT Act is critical to fighting the opioid crisis

A new initiative will help leaders fight the next pandemic

focus

knowledge

hotspot

Apple is now the first public company to be valued at $3 trillion

UnitedHealth CEO's Medicaid comments send insurer stocks diving

Malaria cases in Florida and Texas: Here’s what you need to know

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Hepatitis C has a cure — but many Americans still lack access to it

The most pressing bird flu mysteries scientists want answered

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Medicare Advantage's lean provider networks lead CMS complaints

DIEP, the 'gold standard' of breast reconstruction, is under threat

Illumina board agrees to spin off Grail, as divestment plans proceed

hotspot

Senators tussle over abortion against the backdrop of a presidential campaign

Sutter Health’s antitrust win overturned by appeals court

ASCO Takeaways: Winners, snoozers, and the art of cancer care

The SUPPORT Act is critical to fighting the opioid crisis

FTC loses bid to block Novant's North Carolina hospital merger

New menopause drug shows promise in relief for hot flashes

leisure time

entertainment

explore

hotspot